Application

19296688 · Modulation of Apolipoprotein C-III (ApoCIII) Expression in Lipoprotein Lipase Deficient (LPLD) Populations

Filed 2025-08-11 · Pending The official file ↗ · Art unit OPAP · Examiner Docket Central Easy · CPC A61K 31/7088 · Ionis Pharmaceuticals, Inc. · Arnold & Porter - Ionis

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.